Demant Overview

  • Year Founded
  • 1904

Year Founded

  • Status
  • Public

  • Employees
  • 26,616

Employees

  • Stock Symbol
  • DEMANT

Stock Symbol

  • Investments
  • 30

  • Share Price
  • $50.65
  • (As of Friday Closing)

Demant General Information

Description

Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.

Contact Information

Website
www.demant.com
Formerly Known As
William Demant Holding
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Kongebakken 9
  • 2765 Smorum
  • Denmark
+45 39
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Stock Exchange
CSE
Vertical(s)
Corporate Office
  • Kongebakken 9
  • 2765 Smorum
  • Denmark
+45 39

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Demant Stock Performance

As of 20-Nov-2026, Demant’s stock price is $50.65. Its current market cap is $10.7B with 211M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$50.65 $50.64 $27.05 - $56.78 $10.7B 211M 340K $1.19

Demant Financials Summary

As of 30-Jun-2026, Demant has a trailing 12-month revenue of $3.85B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 11,656,149 9,604,635 10,224,944 11,810,062
Revenue 3,845,956 3,470,584 3,251,991 3,134,687
EBITDA 566,643 767,363 827,104 801,920
Net Income 252,015 233,427 346,247 260,486
Total Assets 6,114,673 6,144,773 4,527,317 4,535,223
Total Debt 3,098,509 3,300,571 2,187,762 2,146,013
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Demant Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Demant‘s full profile, request access.

Request a free trial

Demant Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic
Therapeutic Devices
Smorum, Denmark
26,616 As of 2026

Stafa, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Demant Competitors (1)

One of Demant’s competitors is Sonova, a Formerly PE-Backed company based in Stafa, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonova Formerly PE-Backed Stafa, Switzerland
You’re viewing 1 of 1 competitors. Get the full list »

Demant Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Demant Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Demant‘s full profile, request access.

Request a free trial

Demant Investments & Acquisitions (30)

Demant’s most recent deal was a Merger/Acquisition with KIND (Therapeutic Devices) for . The deal was made on 01-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KIND (Therapeutic Devices) 01-Dec-2025 Merger/Acquisition Therapeutic Devices
OHRWERK Hörgeräte 31-Jan-2025 Merger/Acquisition Distributors (Healthcare)
Dansk HøreCenter 02-Sep-2024 Merger/Acquisition Therapeutic Devices
Fuel Medical Group 01-May-2024 Merger/Acquisition Practice Management (Healthcare)
Hörgeräte-Akustik Flemming & Klingbeil 31-Aug-2023 Merger/Acquisition Therapeutic Devices
You’re viewing 5 of 30 investments and acquisitions. Get the full list »

Demant ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

24.11 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Demant’s complete esg history, request access »

Demant Exits (2)

Demant’s most recent exit was on 01-Jan-2019 from EPOS. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
EPOS 01-Jan-2019 Completed
EPOS 01-Jan-2003 Joint Venture Completed
  • 2 buyers
To view Demant’s complete exits history, request access »

Demant Affiliates

Subsidiaries (38)

Name Industry Location Year Founded
Itsa Medical Vallauris, France 2023
Demant Belgium Leuven, Belgium 2023
Epos Belgium Leuven, Belgium 2022
Epos Sweden Sundbyberg, Sweden 2021
Demant Sales Strategic Accounts Smoerum, Denmark 2019
You’re viewing 5 of 38 affiliates. Get the full list.  »

Demant FAQs

  • When was Demant founded?

    Demant was founded in 1904.

  • Where is Demant headquartered?

    Demant is headquartered in Smorum, Denmark.

  • What is the size of Demant?

    Demant has 26,616 total employees.

  • What industry is Demant in?

    Demant’s primary industry is Therapeutic Devices.

  • Is Demant a private or public company?

    Demant is a Public company.

  • What is Demant’s stock symbol?

    The ticker symbol for Demant is DEMANT.

  • What is the current stock price of Demant?

    As of 20-Nov-2026 the stock price of Demant is $50.65.

  • What is the current market cap of Demant?

    The current market capitalization of Demant is $10.7B.

  • What is Demant’s current revenue?

    The trailing twelve month revenue for Demant is $3.85B.

  • Who are Demant’s competitors?

    Sonova is a competitor of Demant.

  • What is Demant’s annual earnings per share (EPS)?

    Demant’s EPS for 12 months was $1.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process